P3 Health (PIII) Director Granted 2,000 RSUs — Form 4

P3 Health Partners Inc. director Gregory D. Wasson received a grant of 2,000 restricted stock units (RSUs) on 08/06/2025 reported on a Form 4.

Rhea-AI Filing Summary

P3 Health Partners Inc. director Gregory D. Wasson received a grant of 2,000 restricted stock units (RSUs) on 08/06/2025 reported on a Form 4. The RSUs were granted under the 2021 Incentive Award Plan and each RSU represents the right to receive one share of Class A common stock. The award carries a $0 price and vests one year from the grant date. Following the reported transaction, Mr. Wasson is shown as beneficially owning 218,561 shares directly. The filing was signed by an attorney-in-fact on 08/08/2025.

Positive

• 2,000 RSUs granted to Director Gregory D. Wasson under the 2021 Incentive Award Plan
• RSUs vest in one year, providing a clear vesting schedule
• Post-transaction beneficial ownership disclosed: 218,561 shares shown as directly owned

Negative

• None.

Insights

Financial Analyst

TL;DR Routine director equity award: 2,000 RSUs granted, vests in one year, increases reported direct holdings to 218,561 shares.

The Form 4 documents a non-derivative equity grant to a company director. The award is constituted as RSUs under the 2021 Incentive Award Plan, priced at $0 and vesting one year from grant. The filing records the post-transaction beneficial ownership as 218,561 shares, and was executed via attorney-in-fact. This disclosure is consistent with standard director compensation practices and provides clear timing for when the RSUs convert to shares.

Corporate Governance Expert

TL;DR Governance disclosure shows standard equity compensation mechanics and a one-year vesting schedule for a director.

The filing specifies the instrument (RSUs), plan authority (2021 Incentive Award Plan), vesting period (one year), and the exact number of units granted (2,000). It also reports the director's resulting direct beneficial ownership (218,561 shares). The report was timely filed and bears an attorney-in-fact signature, indicating proper procedural handling of the Form 4 disclosure. No additional governance issues are stated in the filing.

Insider Trade Summary

Grant/Award: 2,000 shares

Grant/Award 1 txn

Insider WASSON GREGORY D

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Class A Common Stock	2,000	$0.00	$0.00

Holdings After Transaction: Class A Common Stock — 218,561 shares (Direct)

Footnotes (1)

1. F1. Represents a grant of restricted stock units ("RSUs") granted pursuant to the P3 Health Partners Inc. 2021 Incentive Award Plan. Each RSU represents a right to receive one share of Class A common stock. The RSUs vest in one year from date of grant.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Gregory D. Wasson report on his Form 4 for P3 Health (PIIIW)?

The Form 4 reports a grant of 2,000 RSUs on 08/06/2025 and shows 218,561 shares beneficially owned following the transaction.

Under which plan were the RSUs for P3 Health granted?

The RSUs were granted pursuant to the P3 Health Partners Inc. 2021 Incentive Award Plan.

When do the RSUs awarded to the director vest?

The RSUs vest one year from the date of grant (i.e., one year from 08/06/2025 as stated in the filing).

What price was recorded for the RSU grant on the Form 4?

The Form 4 lists the price as $0, consistent with restricted stock unit awards that convert to shares upon vesting.

Who signed the Form 4 and when was it filed?

The filing was signed by Todd Smith, Chief Legal Officer, as attorney-in-fact on 08/08/2025.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 08/08/2025 - 07:14 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

WASSON GREGORY D

(Last) (First) (Middle)

C/O P3 HEALTH PARTNERS INC.

2370 CORPORATE CIRCLE, SUITE 300

(Street)

HENDERSON NV 89074

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
P3 Health Partners Inc. [ PIII ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/06/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	08/06/2025		A		2,000(1)	A	$0	218,561	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents a grant of restricted stock units ("RSUs") granted pursuant to the P3 Health Partners Inc. 2021 Incentive Award Plan. Each RSU represents a right to receive one share of Class A common stock. The RSUs vest in one year from date of grant.

Remarks:

	/s/Todd Smith, Chief Legal Officer, as attorney-in-fact	08/08/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.